Topical Steroid Withdrawal: Perspectives of Dutch Healthcare Professionals
DOI:
https://doi.org/10.2340/actadv.v105.44209Keywords:
atopic dermatitis, topical corticosteroids, Topical Steroid Withdrawal, Topical Steroid Withdrawal SyndromeAbstract
Topical steroid withdrawal (TSW) is a highly controversial condition, typically reported following prolonged and/or frequent use of topical corticosteroids. Despite growing public awareness, knowledge of topical steroid withdrawal remains limited. Therefore, this study aimed to explore the perspectives of Dutch healthcare professionals (HCPs) on topical steroid withdrawal. A web-based survey was conducted among 168 Dutch HCPs. The results show that erythema (64.1%) and a burning sensation (60.3%) were the most frequently selected symptoms associated with TSW. The majority of respondents (69.6%) attributed TSW symptoms to atopic dermatitis (AD) flares and/or the adverse effect of topical corticosteroid use. Only a small percentage (12.2%) firmly believed that TSW is a distinct clinical entity, while 17.6% believed that it does not exist. Preferred treatments included using other topical immunomodulators, reinitiating and subsequently tapering topical corticosteroids, and providing non-drug and psychological support. While HCPs felt confident in addressing concerns about topical corticosteroids and topical steroid withdrawal, approximately one-quarter (24.2%) preferred not to treat patients refusing topical corticosteroids. This study highlights variations in perception among HCPs and the need for robust research to establish clear diagnostic criteria and guidelines regarding TSW. Finally, improved awareness and open communication between HCPs and patients are essential when addressing topical steroid withdrawal.
Downloads
References
Tan S, Phan P, Law JY, Choi E, Chandran NS. Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients. BMJ Open 2022; 12: e060867. DOI: https://doi.org/10.1136/bmjopen-2022-060867
Hwang J, Lio PA. Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review. J Dermatolog Treat 2022; 33: 1293–1298. DOI: https://doi.org/10.1080/09546634.2021.1882659
National Eczema Society BDNG, British Association of Dermatologists. Topical Steroid Withdrawal [Internet]. 2024. Available from: https://eczema.org/information-and-advice/topical-steroid-withdrawal-tsw/
Hajar T, Leshem YA, Hanifin JM, Nedorost ST, Lio PA, Paller AS, et al. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol 2015; 72: 541–549.e542. DOI: https://doi.org/10.1016/j.jaad.2014.11.024
Barta K, Fonacier LS, Hart M, Lio P, Tullos K, Sheary B, et al. Corticosteroid exposure and cumulative effects in patients with eczema: results from a patient survey. Ann Allergy Asthma Immunol 2023; 130: 93–99.e10. DOI: https://doi.org/10.1016/j.anai.2022.09.031
Tan SY, Chandran NS, Choi EC. Steroid phobia: is there a basis? A review of topical steroid safety, addiction and withdrawal. Clin Drug Investig 2021; 41: 835–842. DOI: https://doi.org/10.1007/s40261-021-01072-z
Marshall HF, Leung DYM, Lack G, Sindher S, Ciaccio CE, Chan S, et al. Topical steroid withdrawal and atopic dermatitis. Ann Allergy Asthma Immunol 2024; 132: 423–425. DOI: https://doi.org/10.1016/j.anai.2023.12.022
Bowe S, Masterson S, Murray G, Haugh I. Topical steroid withdrawal through the lens of social media. Clin Exp Dermatol 2022; 47: 1554–1557. DOI: https://doi.org/10.1111/ced.15194
Haddad F, Abou Shahla W, Saade D. Investigating topical steroid withdrawal videos on TikTok: cross-sectional analysis of the top 100 videos. JMIR Form Res 2024; 8: e48389. DOI: https://doi.org/10.2196/48389
ITSAN. What is TSW Syndrome? Available from: https://www.itsan.org/what-is-tsw-syndrome/
Howells L, Broome H, Burleigh A, Hammond H, Ismail F, Proctor A, et al. Topical corticosteroid withdrawal syndrome: the patient community call for high-quality research, clear definitions and diagnostic criteria. Br J Dermatol 2023; 188: 288–289. DOI: https://doi.org/10.1093/bjd/ljac067
Barlow R, Proctor A, Moss C. Topical steroid withdrawal: a survey of UK dermatologists’ attitudes. Clin Exp Dermatol 2024; 49: 607–611. DOI: https://doi.org/10.1093/ced/llae045
Guckian J, Hughes O, Nikookam Y, Nair R, Brown J, Bewley A, et al. Dermatologist perspectives on topical steroid withdrawal: distrust, disinformation and distance? Br J Dermatol 2023; 188: iv164–iv165. DOI: https://doi.org/10.1093/bjd/ljad113.355
Alsterholm M, Af Klinteberg M, Vrang S, Sigurdardottir G, Sandström Falk M, Shayesteh A. Topical steroid withdrawal in atopic dermatitis: patient-reported characterization from a Swedish social media questionnaire. Acta Derm Venereol 2025; 105: adv40187. DOI: https://doi.org/10.2340/actadv.v105.40187
Brookes TS, Barlow R, Mohandas P, Bewley A. Topical steroid withdrawal: an emerging clinical problem. Clin Exp Dermatol 2023; 48: 1007–1011. DOI: https://doi.org/10.1093/ced/llad161
Sheary B, Harris MF. Cessation of long-term topical steroids in adult atopic dermatitis: a prospective cohort study. Dermatitis 2020; 31: 316–320. DOI: https://doi.org/10.1097/DER.0000000000000602
Ghosh A, Sengupta S, Coondoo A, Jana AK. Topical corticosteroid addiction and phobia. Indian J Dermatol 2014; 59: 465–468. DOI: https://doi.org/10.4103/0019-5154.139876
Feschuk AM, Pratt ME. Topical steroid withdrawal syndrome in a mother and son: a case report. SAGE Open Med Case Rep 2023; 11: 2050313x231164268. DOI: https://doi.org/10.1177/2050313X231164268
Shobnam N, Ratley G, Saksena S, Yadav M, Chaudhary PP, Sun AA, et al. Topical steroid withdrawal is a targetable excess of mitochondrial NAD. J Invest Dermatol 2025, Feb 10 [Online ahead of print] DOI: https://doi.org/10.1101/2024.04.17.24305846
Cotter C, Burton T, Proctor A, Moss C, Flohr C. Topical steroid withdrawal syndrome: time to bridge the gap. Br J Dermatol 2022; 187: 780–781. DOI: https://doi.org/10.1111/bjd.21770
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Florence Vroman, Charlotte S. Schimmel, Lisa P. van der Rijst, Marlies de Graaf, Marjolein de Bruin-Weller, Patrick M.J.H. Kemperman, Dirk Jan Hijnen, Inge M. Haeck
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
